small dose glp 1 GLP-1 Microdosing Can You Take a GLP-1

The Key Risk: Euglycemic DKA One of the most serious concerns with GLP-1 use in Type 1 diabetes is euglycemic DKA a form of diabetic ketoacidosis where blood glucose may not be severely elevated

By helping patients feel fuller longer and reducing cravings, this therapy can support healthier eating habits and sustainable weight management when combined with proper nutrition and lifestyle choices.* The sublingual delivery system is designed for absorption under the tongue, offering a simple and approachable option for patients seeking an alternative to injectable therapies

The mechanism is most parsimoniously explained as telogen effluvium secondary to rapid weight loss and metabolic stress

This allows it to reach room temperature naturally

Can I inject every 5 days instead of 7 to boost the effect?+ No